| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |